Significance: Neurodegenerative diseases are characterized by progressive loss of neurons. A common feature is oxidative stress, which arises when reactive oxygen species (ROS) and/or reactive nitrogen species (RNS) exceed amounts required for normal redox signaling. An imbalance in ROS/RNS alters functionality of cysteines and perturbs thiol–disulfide homeostasis. Many cysteine modifications may occur, but reversible protein mixed disulfides with glutathione (GSH) likely represents the common steady-state derivative due to cellular abundance of GSH and ready conversion of cysteine-sulfenic acid and S-nitrosocysteine precursors to S-glutathionylcysteine disulfides. Thus, S-glutathionylation acts in redox signal transduction and serves as a protective mechanism against irreversible cysteine oxidation. Reversal of protein-S-glutathionylation is catalyzed specifically by glutaredoxin which thereby plays a critical role in cellular regulation. This review highlights the role of oxidative modification of proteins, notably S-glutathionylation, and alterations in thiol homeostatic enzyme activities in neurodegenerative diseases, providing insights for therapeutic intervention. Recent Advances: Recent studies show that dysregulation of redox signaling and sulfhydryl homeostasis likely contributes to onset/progression of neurodegeneration. Oxidative stress alters the thiol–disulfide status of key proteins that regulate the balance between cell survival and cell death. Critical Issues: Much of the current information about redox modification of key enzymes and signaling intermediates has been gleaned from studies focused on oxidative stress situations other than the neurodegenerative diseases. Future Directions: The findings in other contexts are expected to apply to understanding neurodegenerative mechanisms. Identification of selectively glutathionylated proteins in a quantitative fashion will provide new insights about neuropathological consequences of this oxidative protein modification. Antioxid. Redox Signal. 16, 543–566.
AdachiT, PimentelDR, HeibeckT, HouX, LeeYJ, JiangB, IdoY, CohenRA. S-glutathiolation of Ras mediates redox-sensitive signaling by angiotensin II in vascular smooth muscle cells. J Biol Chem, 279:29857–29862. 2004.
2.
AdachiT, WeisbrodRM, PimentelDR, YingJ, SharovVS, SchoneichC, CohenRA. S-Glutathiolation by peroxynitrite activates SERCA during arterial relaxation by nitric oxide. Nat Med, 10:1200–1207. 2004.
3.
Adam-ViziV. Production of reactive oxygen species in brain mitochondria: Contribution by electron transport chain and non-electron transport chain sources. Antioxid Redox Signal, 7:1140–1149. 2005.
4.
AksenovMY, AksenovaMV, ButterfieldDA, GeddesJW, MarkesberyWR. Protein oxidation in the brain in Alzheimer's disease. Neuroscience, 103:373–383. 2001.
5.
AkterinS, CowburnRF, Miranda-VizueteA, JimenezA, BogdanovicN, WinbladB, Cedazo-MinguezA. Involvement of glutaredoxin-1 and thioredoxin-1 in beta-amyloid toxicity and Alzheimer's disease. Cell Death Differ, 13:1454–1465. 2006.
6.
AnsariMA, ScheffSW. Oxidative stress in the progression of Alzheimer disease in the frontal cortex. J Neuropathol Exp Neurol, 69:155–167. 2010.
7.
AraJ, PrzedborskiS, NainiAB, Jackson-LewisV, TrifilettiRR, HorwitzJ, IschiropoulosH. Inactivation of tyrosine hydroxylase by nitration following exposure to peroxynitrite and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)Proc Natl Acad Sci USA, 95:7659–7663. 1998.
8.
Aracena-ParksP, GoonasekeraSA, GilmanCP, DirksenRT, HidalgoC, HamiltonSL. Identification of cysteines involved in S-nitrosylation, S-glutathionylation, and oxidation to disulfides in ryanodine receptor type 1. J Biol Chem, 281:40354–40368. 2006.
9.
AramL, GeulaS, ArbelN, Shoshan-BarmatzV. VDAC1 cysteine residues: Topology and function in channel activity and apoptosis. Biochem J, 427:445–454. 2010.
10.
AranM, FerreroDS, PaganoE, WolosiukRA. Typical 2-Cys peroxiredoxins—Modulation by covalent transformations and noncovalent interactions. FEBS J, 276:2478–2493. 2009.
11.
ArmenteroMT, PinnaA, FerreS, LanciegoJL, MullerCE, FrancoR. Past, present and future of A(2A) adenosine receptor antagonists in the therapy of Parkinson's disease. Pharmacol Ther, 132:280–299. 2011.
12.
BainesCP, KaiserRA, PurcellNH, BlairNS, OsinskaH, HambletonMA, BrunskillEW, SayenMR, GottliebRA, DornGW, RobbinsJ, MolkentinJD. Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature, 434:658–662. 2005.
13.
BainesCP, KaiserRA, SheikoT, CraigenWJ, MolkentinJD. Voltage-dependent anion channels are dispensable for mitochondrial-dependent cell death. Nat Cell Biol, 9:550–555. 2007.
14.
BandyopadhyayS, StarkeDW, MieyalJJ, GronostajskiRM. Thioltransferase (glutaredoxin) reactivates the DNA-binding activity of oxidation-inactivated nuclear factor I. J Biol Chem, 273:392–397. 1998.
15.
BarrettWC, DeGnoreJP, KengYF, ZhangZY, YimMB, ChockPB. Roles of superoxide radical anion in signal transduction mediated by reversible regulation of protein-tyrosine phosphatase 1B. J Biol Chem, 274:34543–34546. 1999.
16.
BarrettWC, DeGnoreJP, KonigS, FalesHM, KengYF, ZhangZY, YimMB, ChockPB. Regulation of PTP1B via glutathionylation of the active site cysteine 215. Biochemistry, 38:6699–6705. 1999.
17.
BedardK, KrauseKH. The NOX family of ROS-generating NADPH oxidases: Physiology and pathophysiology. Physiol Rev, 87:245–313. 2007.
18.
BeerSM, TaylorER, BrownSE, DahmCC, CostaNJ, RunswickMJ, MurphyMP. Glutaredoxin 2 catalyzes the reversible oxidation and glutathionylation of mitochondrial membrane thiol proteins: Implications for mitochondrial redox regulation and antioxidant DEFENSE. J Biol Chem, 279:47939–47951. 2004.
BenharM, ForresterMT, StamlerJS. Protein denitrosylation: Enzymatic mechanisms and cellular functions. Nat Rev Mol Cell Biol, 10:721–732. 2009.
21.
BorgesCR, GeddesT, WatsonJT, KuhnDM. Dopamine biosynthesis is regulated by S-glutathionylation. Potential mechanism of tyrosine hydroxylase inhibition during oxidative stress. J Biol Chem, 277:48295–48302. 2002.
22.
BossyB, PetrilliA, KlinglmayrE, ChenJ, Lutz-MeindlU, KnottAB, MasliahE, SchwarzenbacherR, Bossy-WetzelE. S-Nitrosylation of DRP1 does not affect enzymatic activity and is not specific to Alzheimer's disease. J Alzheimers Dis, 20,Suppl 2:S513–S526. 2010.
23.
BredesenDE, RaoRV, MehlenP. Cell death in the nervous system. Nature, 443:796–802. 2006.
24.
BrochardV, CombadiereB, PrigentA, LaouarY, PerrinA, Beray-BerthatV, BonduelleO, Varez-FischerD, CallebertJ, LaunayJM, DuyckaertsC, FlavellRA, HirschEC, HunotS. Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease. J Clin Invest, 119:182–192. 2009.
25.
BullR, FinkelsteinJP, GalvezJ, SanchezG, DonosoP, BehrensMI, HidalgoC. Ischemia enhances activation by Ca2+ and redox modification of ryanodine receptor channels from rat brain cortex. J Neurosci, 28:9463–9472. 2008.
26.
CalabreseV, CorneliusC, RizzarelliE, OwenJB, Dinkova-KostovaAT, ButterfieldDA. Nitric oxide in cell survival: A janus molecule. Antioxid Redox Signal, 11:2717–2739. 2009.
CarboneDL, DoornJA, KieblerZ, IckesBR, PetersenDR. Modification of heat shock protein 90 by 4-hydroxynonenal in a rat model of chronic alcoholic liver disease. J Pharmacol Exp Ther, 315:8–15. 2005.
29.
CarboneDL, DoornJA, KieblerZ, SampeyBP, PetersenDR. Inhibition of Hsp72-mediated protein refolding by 4-hydroxy-2-nonenal. Chem Res Toxicol, 17:1459–1467. 2004.
30.
CasagrandeS, BonettoV, FratelliM, GianazzaE, EberiniI, MassignanT, SalmonaM, ChangG, HolmgrenA, GhezziP. Glutathionylation of human thioredoxin: A possible crosstalk between the glutathione and thioredoxin systems. Proc Natl Acad Sci USA, 99:9745–9749. 2002.
31.
CeniniG, SultanaR, MemoM, ButterfieldDA. Effects of oxidative and nitrosative stress in brain on p53 proapoptotic protein in amnestic mild cognitive impairment and Alzheimer disease. Free Radic Biol Med, 45:81–85. 2008.
32.
ChenCA, WangTY, VaradharajS, ReyesLA, HemannC, TalukderMA, ChenYR, DruhanLJ, ZweierJL. S-glutathionylation uncouples eNOS and regulates its cellular and vascular function. Nature, 468:1115–1118. 2010.
33.
ChenCL, ChenJ, RawaleS, VaradharajS, KaumayaPP, ZweierJL, ChenYR. Protein tyrosine nitration of the flavin subunit is associated with oxidative modification of mitochondrial complex II in the post-ischemic myocardium. J Biol Chem, 283:27991–28003. 2008.
34.
ChenVT, HuangCL, LeeYC, LiaoWC, HuangNK. The roles of the thioredoxin system and peroxiredoxins in 1-methyl-4-phenyl-pyridinium ion-induced cytotoxicity in rat pheochromocytoma cells. Toxicol In Vitro, 1577–1583. 2010.
35.
ChenYR, ChenCL, PfeifferDR, ZweierJL. Mitochondrial complex II in the post-ischemic heart: oxidative injury and the role of protein S-glutathionylation. J Biol Chem, 282:32640–32654. 2007.
ChungS, SundarIK, YaoH, HoYS, RahmanI. Glutaredoxin 1 regulates cigarette smoke-mediated lung inflammation through differential modulation of I{kappa}B kinases in mice: Impact on histone acetylation. Am J Physiol Lung Cell Mol Physiol, 299:L192–L203. 2010.
39.
CrabbJW, MiyagiM, GuX, ShadrachK, WestKA, SakaguchiH, KameiM, HasanA, YanL, RaybornME, SalomonRG, HollyfieldJG. Drusen proteome analysis: An approach to the etiology of age-related macular degeneration. Proc Natl Acad Sci USA, 99:14682–14687. 2002.
40.
DagdaRK, ChuCT. Mitochondrial quality control: Insights on how Parkinson's disease related genes PINK1, parkin, and Omi/HtrA2 interact to maintain mitochondrial homeostasis. J Bioenerg Biomembr, 41:473–479. 2009.
41.
DailyD, Vlamis-GardikasA, OffenD, MittelmanL, MelamedE, HolmgrenA, BarzilaiA. Glutaredoxin protects cerebellar granule neurons from dopamine-induced apoptosis by activating NF-kappa B via Ref-1. J Biol Chem, 276:1335–1344. 2001.
42.
DailyD, Vlamis-GardikasA, OffenD, MittelmanL, MelamedE, HolmgrenA, BarzilaiA. Glutaredoxin protects cerebellar granule neurons from dopamine-induced apoptosis by dual activation of the ras-phosphoinositide 3-kinase and jun n-terminal kinase pathways. J Biol Chem, 276:21618–21626. 2001.
43.
DavisDA, NewcombFM, StarkeDW, OttDE, MieyalJJ, YarchoanR. Thioltransferase (glutaredoxin) is detected within HIV-1 and can regulate the activity of glutathionylated HIV-1 protease in vitro. J Biol Chem, 272:25935–25940. 1997.
44.
DemasiM, SilvaGM, NettoLE. 20 S proteasome from Saccharomyces cerevisiae is responsive to redox modifications and is S-glutathionylated. J Biol Chem, 278:679–685. 2003.
45.
Di NotoL. Biochemical Investigation of Tau and MAP2: Polymerization implications for neuropathic filament assembly in Alzheimer's disease (Dissertation)University of Florida: Gainsville, FL, 2002.
46.
Di NotoL, DetureMA, PurichDL. Structural insights into Alzheimer filament assembly pathways based on site-directed mutagenesis and S-glutathionylation of three-repeat neuronal Tau protein. Microsc Res Tech, 67:156–163. 2005.
47.
DiDF, CeniniG, SultanaR, PerluigiM, UbertiD, MemoM, ButterfieldDA. Glutathionylation of the pro-apoptotic protein p53 in Alzheimer's disease brain: Implications for AD pathogenesis. Neurochem Res, 34:727–733. 2009.
48.
DickinsonBC, PeltierJ, StoneD, SchafferDV, ChangCJ. Nox2 redox signaling maintains essential cell populations in the brain. Nat Chem Biol, 7:106–112. 2011.
49.
DoubleKL, ToddG, DumaSR. Pathophysiology of transcranial sonography signal changes in the human substantia nigra. Int Rev Neurobiol, 90:107–120. 2010.
50.
DuZX, YanY, ZhangHY, LiuBQ, GaoYY, NiuXF, GuanY, MengX, WangHQ. Suppression of MG132-mediated cell death by peroxiredoxin 1 through influence on ASK1 activation in human thyroid cancer cells. Endocr Relat Cancer, 17:553–560. 2010.
51.
EhrhartJ, GluckM, MieyalJ, ZeevalkGD. Functional glutaredoxin (thioltransferase) activity in rat brain and liver mitochondria. Parkinsonism Relat Disord, 8:395–400. 2002.
52.
FarinaC, AloisiF, MeinlE. Astrocytes are active players in cerebral innate immunity. Trends Immunol, 28:138–145. 2007.
53.
FataniaHR, al-NassarKE, ThomasN. Chemical modification of rat liver cytosolic NADP(+)-linked isocitrate dehydrogenase by N-ethylmaleimide. Evidence for essential sulphydryl groups. FEBS Lett, 322:245–248. 1993.
54.
FerriA, FiorenzoP, NenciniM, CozzolinoM, PesaresiMG, ValleC, SepeS, MorenoS, CarriMT. Glutaredoxin 2 prevents aggregation of mutant SOD1 in mitochondria and abolishes its toxicity. Hum Mol Genet, 19:4529–4542. 2010.
55.
FerringtonDA, KapphahnRJ. Catalytic site-specific inhibition of the 20S proteasome by 4-hydroxynonenal. FEBS Lett, 578:217–223. 2004.
56.
FindlayVJ, TownsendDM, MorrisTE, FraserJP, HeL, TewKD. A novel role for human sulfiredoxin in the reversal of glutathionylation. Cancer Res, 66:6800–6806. 2006.
FosterMW, HessDT, StamlerJS. Protein S-nitrosylation in health and disease: A current perspective. Trends Mol Med, 15:391–404. 2009.
59.
FrancoR, CidlowskiJA. Apoptosis and glutathione: Beyond an antioxidant. Cell Death Differ, 16:1303–1314. 2009.
60.
FriguetB, SzwedaLI. Inhibition of the multicatalytic proteinase (proteasome) by 4-hydroxy-2-nonenal cross-linked protein. FEBS Lett, 405:21–25. 1997.
61.
FujiiH, IchimoriK, HoshiaiK, NakazawaH. Nitric oxide inactivates NADPH oxidase in pig neutrophils by inhibiting its assembling process. J Biol Chem, 272:32773–32778. 1997.
62.
FuxeKG, TarakanovAO, GoncharovaLB, AgnatiLF. A new road to neuroinflammation in Parkinson's disease?Brain Res Rev, 58:453–458. 2008.
63.
GalganskaH, KarachitosA, WojtkowskaM, StobieniaO, BudzinskaM, KmitaH. Communication between mitochondria and nucleus: Putative role for VDAC in reduction/oxidation mechanism. Biochim Biophys Acta, 1797:1276–1280. 2010.
64.
GalloglyMM, MieyalJJ. Mechanisms of reversible protein glutathionylation in redox signaling and oxidative stress. Curr Opin Pharmacol, 7:381–391. 2007.
65.
GalloglyMM, StarkeDW, MieyalJJ. Mechanistic and kinetic details of catalysis of thiol-disulfide exchange by glutaredoxins and potential mechanisms of regulation. Antioxid Redox Signal, 11:1059–1081. 2009.
66.
GarciaJ, HanD, SanchetiH, YapLP, KaplowitzN, CadenasE. Regulation of mitochondrial glutathione redox status and protein glutathionylation by respiratory substrates. J Biol Chem, 285:39646–39654. 2010.
HalestrapAP, ClarkeSJ, KhaliulinI. The role of mitochondria in protection of the heart by preconditioning. Biochim Biophys Acta, 1767:1007–1031. 2007.
72.
HashemySI, JohanssonC, BerndtC, LilligCH, HolmgrenA. Oxidation and S-nitrosylation of cysteines in human cytosolic and mitochondrial glutaredoxins: Effects on structure and activity. J Biol Chem, 282:14428–14436. 2007.
73.
HeutinkP. PINK-1 and DJ-1–new genes for autosomal recessive Parkinson's disease. J Neural Transm Suppl, 215–219. 2006.
74.
HickeyWF. Basic principles of immunological surveillance of the normal central nervous system. Glia, 36:118–124. 2001.
75.
HirschEC, HunotS. Neuroinflammation in Parkinson's disease: A target for neuroprotection?Lancet Neurol, 8:382–397. 2009.
76.
HuX, WengZ, ChuCT, ZhangL, CaoG, GaoY, SignoreA, ZhuJ, HastingsT, GreenamyreJT, ChenJ. Peroxiredoxin-2 protects against 6-hydroxydopamine-induced dopaminergic neurodegeneration via attenuation of the apoptosis signal-regulating kinase (ASK1) signaling cascade. J Neurosci, 31:247–261. 2011.
HurdTR, RequejoR, FilipovskaA, BrownS, PrimeTA, RobinsonAJ, FearnleyIM, MurphyMP. Complex I within oxidatively stressed bovine heart mitochondria is glutathionylated on Cys-531 and Cys-704 of the 75-kDa subunit: Potential role of CYS residues in decreasing oxidative damage. J Biol Chem, 283:24801–24815. 2008.
79.
ImamSZ, ZhouQ, YamamotoA, ValenteAJ, AliSF, BainsM, RobertsJL, KahlePJ, ClarkRA, LiS. Novel regulation of parkin function through c-Abl-mediated tyrosine phosphorylation: Implications for Parkinson's disease. J Neurosci, 31:157–163. 2011.
80.
InfangerDW, SharmaRV, DavissonRL. NADPH oxidases of the brain: Distribution, regulation, and function. Antioxid Redox Signal, 8:1583–1596. 2006.
81.
IqbalK, Grundke-IqbalI. Opportunities and challenges in developing Alzheimer disease therapeutics. Acta Neuropathol, 122:543–549. 2011.
82.
IschiropoulosH, BeckmanJS. Oxidative stress and nitration in neurodegeneration: Cause, effect, or association?J Clin Invest, 111:163–169. 2003.
83.
JacobC, KnightI, WinyardPG. Aspects of the biological redox chemistry of cysteine: From simple redox responses to sophisticated signalling pathways. Biol Chem, 387:1385–1397. 2006.
84.
Jahngen-HodgeJ, ObinMS, GongX, ShangF, NowellTRJr., GongJ, AbasiH, BlumbergJ, TaylorA. Regulation of ubiquitin-conjugating enzymes by glutathione following oxidative stress. J Biol Chem, 272:28218–28226. 1997.
85.
JennerP, DexterDT, SianJ, SchapiraAH, MarsdenCD. Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental Lewy body disease. The Royal Kings and Queens Parkinson's Disease Research Group. Ann Neurol, 32,Suppl:S82–S87. 1992.
86.
JhaN, KumarMJ, BoonplueangR, AndersenJK. Glutathione decreases in dopaminergic PC12 cells interfere with the ubiquitin protein degradation pathway: Relevance for Parkinson's disease?J Neurochem, 80:555–561. 2002.
87.
JunnE, TaniguchiH, JeongBS, ZhaoX, IchijoH, MouradianMM. Interaction of DJ-1 with Daxx inhibits apoptosis signal-regulating kinase 1 activity and cell death. Proc Natl Acad Sci USA, 102:9691–9696. 2005.
88.
KarunakaranS, DiwakarL, SaeedU, AgarwalV, RamakrishnanS, IyengarS, RavindranathV. Activation of apoptosis signal regulating kinase 1 (ASK1) and translocation of death-associated protein, Daxx, in substantia nigra pars compacta in a mouse model of Parkinson's disease: Protection by alpha-lipoic acid. FASEB J, 21:2226–2236. 2007.
89.
KarunakaranS, SaeedU, RamakrishnanS, KoumarRC, RavindranathV. Constitutive expression and functional characterization of mitochondrial glutaredoxin (Grx2) in mouse and human brain. Brain Res, 1185:8–17. 2007.
90.
KawamataH, ManfrediG. Import, maturation, and function of SOD1 and its copper chaperone CCS in the mitochondrial intermembrane space. Antioxid Redox Signal, 13:1375–1384. 2010.
91.
KenchappaRS, RavindranathV. Glutaredoxin is essential for maintenance of brain mitochondrial complex I: Studies with MPTP. FASEB J, 17:717–719. 2003.
92.
KiddSK, SchneiderJS. Protective effects of valproic acid on the nigrostriatal dopamine system in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease. Neuroscience, 194:189–194. 2011.
KilIS, ParkJW. Regulation of mitochondrial NADP+ -dependent isocitrate dehydrogenase activity by glutathionylation. J Biol Chem, 280:10846–10854. 2005.
95.
KimRH, SmithPD, AleyasinH, HayleyS, MountMP, PownallS, WakehamA, You-TenAJ, KaliaSK, HorneP, WestawayD, LozanoAM, AnismanH, ParkDS, MakTW. Hypersensitivity of DJ-1-deficient mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrindine (MPTP) and oxidative stress. Proc Natl Acad Sci USA, 102:5215–5220. 2005.
96.
KimSY, KimTJ, LeeKY. A novel function of peroxiredoxin 1 (Prx-1) in apoptosis signal-regulating kinase 1 (ASK1)-mediated signaling pathway. FEBS Lett, 582:1913–1918. 2008.
97.
KiyotaT, IngrahamKL, SwanRJ, JacobsenMT, AndrewsSJ, IkezuT. AAV serotype 2/1-mediated gene delivery of anti-inflammatory interleukin-10 enhances neurogenesis and cognitive function in APP+PS1 mice. Gene Ther, 2011Sep15 DOI:10.1038/gt.2011.126. [Epub ahead of print]http://www.ncbi.nim.nih.gov/pubmed/21918553.
98.
KlattP, MolinaEP, LamasS. Nitric oxide inhibits c-Jun DNA binding by specifically targeted S-glutathionylation. J Biol Chem, 274:15857–15864. 1999.
99.
KokoszkaJE, WaymireKG, LevySE, SlighJE, CaiJ, JonesDP, MacGregorGR, WallaceDC. The ADP/ATP translocator is not essential for the mitochondrial permeability transition pore. Nature, 427:461–465. 2004.
LamPY, YinF, HamiltonRT, BoverisA, CadenasE. Elevated neuronal nitric oxide synthase expression during ageing and mitochondrial energy production. Free Radic Res, 43:431–439. 2009.
102.
LeeDW, KaurD, ChintaSJ, RajagopalanS, AndersenJ. A Disruption in iron-sulfur center biogenesis via inhibition of mitochondrial dithiol glutaredoxin 2 may contribute to mitochondrial and cellular iron dysregulation in mammalian glutathione-depleted dopaminergic cells: Implications for Parkinsons disease. Antioxid Redox Signal, 9:2083–2094. 2009.
103.
LeeYM, ParkSH, ShinDI, HwangJY, ParkB, ParkYJ, LeeTH, ChaeHZ, JinBK, OhTH, OhYJ. Oxidative modification of peroxiredoxin is associated with drug-induced apoptotic signaling in experimental models of Parkinson disease. J Biol Chem, 283:9986–9998. 2008.
LilligCH, BerndtC, VergnolleO, LonnME, HudemannC, BillE, HolmgrenA. Characterization of human glutaredoxin 2 as iron-sulfur protein: A possible role as redox sensor. Proc Natl Acad Sci USA, 102:8168–8173. 2005.
106.
LinMT, BealMF. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature, 443:787–795. 2006.
LowtherWT, HaynesAC. Reduction of cysteine sulfinic acid in eukaryotic, typical 2-Cys peroxiredoxins by sulfiredoxin. Antioxid Redox Signal, 15:99–109. 2011.
109.
Maguire-ZeissKA, ShortDW, FederoffHJ. Synuclein, dopamine and oxidative stress: Co-conspirators in Parkinson's disease?Brain Res Mol Brain Res, 134:18–23. 2005.
110.
MaillouxRJ, SeifertEL, BouillaudF, AguerC, CollinsS, HarperME. Glutathionylation acts as a control switch for uncoupling proteins UCP2 and UCP3. J Biol Chem, 286:21865–21875. 2011.
MartinHL, TeismannP. Glutathione—A review on its role and significance in Parkinson's disease. FASEB J, 23:3263–3272. 2009.
114.
MatsuzawaA, IchijoH. Redox control of cell fate by MAP kinase: Physiological roles of ASK1-MAP kinase pathway in stress signaling. Biochim Biophys Acta, 1780:1325–1336. 2008.
115.
MattsonMP. Calcium and neurodegeneration. Aging Cell, 6:337–350. 2007.
116.
MazzolaJL, SiroverMA. Reduction of glyceraldehyde-3-phosphate dehydrogenase activity in Alzheimer's disease and in Huntington's disease fibroblasts. J Neurochem, 76:442–449. 2001.
117.
McGeerPL, ItagakiS, BoyesBE, McGeerEG. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology, 38:1285–1291. 1988.
118.
MieyalJJ, GalloglyMM, QanungoS, SabensEA, SheltonMD. Molecular mechanisms and clinical implications of reversible protein S-glutathionylation. Antioxid Redox Signal, 10:1941–1988. 2008.
119.
MieyalJJ, SrinivasanU, StarkeDW, GravinaSA, MieyalPA. Glutathionyl specificity of the thioltransferases: Mechanistic and physiological implications. PackerL, CadenasE.1995. Marcel Dekker, Inc.Biothiols in Health and Disease. Ref Type: Serial (Book, Monograph)305–372.
120.
MogiM, KondoT, MizunoY, NagatsuT. p53 protein, interferon-gamma, and NF-kappaB levels are elevated in the parkinsonian brain. Neurosci Lett, 414:94–97. 2007.
121.
MohrS, HallakH, de BoitteA, LapetinaEG, BruneB. Nitric oxide-induced S-glutathionylation and inactivation of glyceraldehyde-3-phosphate dehydrogenase. J Biol Chem, 274:9427–9430. 1999.
122.
MurataH, IharaY, NakamuraH, YodoiJ, SumikawaK, KondoT. Glutaredoxin exerts an antiapoptotic effect by regulating the redox state of Akt. J Biol Chem, 278:50226–50233. 2003.
123.
NakajimaH, AmanoW, FujitaA, FukuharaA, AzumaYT, HataF, InuiT, TakeuchiT. The active site cysteine of the proapoptotic protein glyceraldehyde-3-phosphate dehydrogenase is essential in oxidative stress-induced aggregation and cell death. J Biol Chem, 282:26562–26574. 2007.
124.
NakamuraT, LiptonSA. Redox modulation by S-nitrosylation contributes to protein misfolding, mitochondrial dynamics, and neuronal synaptic damage in neurodegenerative diseases. Cell Death Differ, 18:1478–1486. 2011.
125.
NassifM, HetzC. Targeting autophagy in ALS: A complex mission. Autophagy, 7:450–453. 2011.
126.
NewmanSF, SultanaR, PerluigiM, CocciaR, CaiJ, PierceWM, KleinJB, TurnerDM, ButterfieldDA. An increase in S-glutathionylated proteins in the Alzheimer's disease inferior parietal lobule. A proteomics approach. J Neurosci Res, 85:1506–1514. 2007.
NorenbergMD, RaoKV. The mitochondrial permeability transition in neurologic disease. Neurochem Int, 50:983–997. 2007.
129.
Nulton-PerssonAC, StarkeDW, MieyalJJ, SzwedaLI. Reversible inactivation of alpha-ketoglutarate dehydrogenase in response to alterations in the mitochondrial glutathione status. Biochemistry, 42:4235–4242. 2003.
130.
ObinM, ShangF, GongX, HandelmanG, BlumbergJ, TaylorA. Redox regulation of ubiquitin-conjugating enzymes: Mechanistic insights using the thiol-specific oxidant diamide. FASEB J, 12:561–569. 1998.
131.
OkadaK, WangpoengtrakulC, OsawaT, ToyokuniS, TanakaK, UchidaK. 4-Hydroxy-2-nonenal-mediated impairment of intracellular proteolysis during oxidative stress. Identification of proteasomes as target molecules. J Biol Chem, 274:23787–23793. 1999.
132.
OkunE, GriffioenKJ, LathiaJD, TangSC, MattsonMP, ArumugamTV. Toll-like receptors in neurodegeneration. Brain Res Rev, 59:278–292. 2009.
133.
OlanowCW, TattonWG. Etiology and pathogenesis of Parkinson's disease. Annu Rev Neurosci, 22:123–144. 1999.
OuyangM, ShenX. Critical role of ASK1 in the 6-hydroxydopamine-induced apoptosis in human neuroblastoma SH-SY5Y cells. J Neurochem, 97:234–244. 2006.
136.
PaiHV, StarkeDW, LesnefskyEJ, HoppelCL, MieyalJJ. What is the functional significance of the unique location of glutaredoxin 1 (GRx1) in the intermembrane space of mitochondria?Antioxid Redox Signal, 9:2027–2033. 2007.
137.
PappollaMA, OmarRA, KimKS, RobakisNK. Immunohistochemical evidence of oxidative [corrected] stress in Alzheimer's disease. Am J Pathol, 140:621–628. 1992.
138.
ParkHS, ChoSG, KimCK, HwangHS, NohKT, KimMS, HuhSH, KimMJ, RyooK, KimEK, KangWJ, LeeJS, SeoJS, KoYG, KimS, ChoiEJ. Heat shock protein hsp72 is a negative regulator of apoptosis signal-regulating kinase 1. Mol Cell Biol, 22:7721–7730. 2002.
139.
ParkJW, MieyalJJ, RheeSG, ChockPB. Deglutathionylation of 2-Cys peroxiredoxin is specifically catalyzed by sulfiredoxin. J Biol Chem, 284:23364–23374. 2009.
140.
PastoreA, TozziG, GaetaLM, BertiniE, SerafiniV, Di CesareS, BonettoV, CasoniF, CarrozzoR, FedericiG, PiemonteF. Actin glutathionylation increases in fibroblasts of patients with Friedreich's ataxia: A potential role in the pathogenesis of the disease. J Biol Chem, 278:42588–42595. 2003.
141.
PattenDA, GermainM, KellyMA, SlackRS. Reactive oxygen species: Stuck in the middle of neurodegeneration. J Alzheimers Dis, 20,Suppl 2:S357–S367. 2010.
142.
PearceRK, OwenA, DanielS, JennerP, MarsdenCD. Alterations in the distribution of glutathione in the substantia nigra in Parkinson's disease. J Neural Transm, 104:661–677. 1997.
QueirogaCS, AlmeidaAS, MartelC, BrennerC, AlvesPM, VieiraHL. Glutathionylation of adenine nucleotide translocase induced by carbon monoxide prevents mitochondrial membrane permeabilization and apoptosis. J Biol Chem, 285:17077–17088. 2010.
150.
ReddyPH. Mitochondrial dysfunction in aging and Alzheimer's disease: Strategies to protect neurons. Antioxid Redox Signal, 9:1647–1658. 2007.
151.
ReynaertNL, van der VlietA, GualaAS, McGovernT, HristovaM, PantanoC, HeintzNH, HeimJ, HoYS, MatthewsDE, WoutersEF, Janssen-HeiningerYM. Dynamic redox control of NF-kappaB through glutaredoxin-regulated S-glutathionylation of inhibitory kappaB kinase beta. Proc Natl Acad Sci USA, 103:13086–13091. 2006.
152.
RiedlererPF. Views on neurodegeneration as a basis for neuroprotective strategies. Med Sci Monit, 10:RA287–RA290. 2004.
153.
RomeroJM, BizzozeroOA. Intracellular glutathione mediates the denitrosylation of protein nitrosothiols in the rat spinal cord. J Neurosci Res, 87:701–709. 2009.
154.
SabensEA, DistlerAM, MieyalJJ. Levodopa deactivates enzymes that regulate thiol-disulfide homeostasis and promotes neuronal cell death: Implications for therapy of Parkinson's disease. Biochemistry, 49:2715–2724. 2010.
155.
SabensE, StellarK, MieyalJJ. Levodopa activates apoptosis activating kinase 1 (ASK1) and promotes apoptosis in a neuronal model: Implications for Parkinson's disease. Chem Res in Toxicol, 24:1644–1652. 2011.
156.
SaeedU, DurgadossL, ValliRK, JoshiDC, JoshiPG, RavindranathV. Knockdown of cytosolic glutaredoxin 1 leads to loss of mitochondrial membrane potential: Implication in neurodegenerative diseases. PLoS ONE, 3:e2459. 2008.
157.
SaeedU, RayA, ValliRK, KumarAM, RavindranathV. DJ-1 Loss by glutaredoxin but not glutathione depletion triggers Daxx translocation and cell death. Antioxid Redox Signal, 13:127–144. 2010.
158.
SaitohM, NishitohH, FujiiM, TakedaK, TobiumeK, SawadaY, KawabataM, MiyazonoK, IchijoH. Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J, 17:2596–2606. 1998.
SheltonMD, ChockPB, MieyalJJ. Glutaredoxin: Role in reversible protein S-glutathionylation and regulation of redox signal transduction and protein translocation. Antioxid Redox Signal, 7:348–366. 2005.
SheltonMD, KernTS, MieyalJJ. Glutaredoxin regulates nuclear factor kappa-B and intercellular adhesion molecule in Muller cells: Model of diabetic retinopathy. J Biol Chem, 282:12467–12474. 2007.
164.
ShiQ, XuH, YuH, ZhangN, YeY, EstevezAG, DengH, GibsonGE. Inactivation and reactivation of the mitochondrial {alpha}-ketoglutarate dehydrogenase complex. J Biol Chem, 286:17640–17648. 2011.
165.
ShimohamaS, TaninoH, KawakamiN, OkamuraN, KodamaH, YamaguchiT, HayakawaT, NunomuraA, ChibaS, PerryG, SmithMA, FujimotoS. Activation of NADPH oxidase in Alzheimer's disease brains. Biochem Biophys Res Commun, 273:5–9. 2000.
166.
ShinJH, KoHS, KangH, LeeY, LeeYI, PletinkovaO, TroconsoJC, DawsonVL, DawsonTM. PARIS (ZNF746) repression of PGC-1alpha contributes to neurodegeneration in Parkinson's disease. Cell, 144:689–702. 2011.
167.
SianJ, DexterDT, LeesAJ, DanielS, AgidY, Javoy-AgidF, JennerP, MarsdenCD. Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia. Ann Neurol, 36:348–355. 1994.
168.
SmithMA, NunomuraA, ZhuX, TakedaA, PerryG. Metabolic, metallic, and mitotic sources of oxidative stress in Alzheimer disease. Antioxid Redox Signal, 2:413–420. 2000.
169.
SmythGE, ColmanRF. Cysteinyl peptides of pig heart NADP-dependent isocitrate dehydrogenase that are modified upon inactivation by N-ethylmaleimide. J Biol Chem, 266:14918–14925. 1991.
170.
SongIS, KimSU, OhNS, KimJ, YuDY, HuangSM, KimJM, LeeDS, KimNS. Peroxiredoxin I contributes to TRAIL resistance through suppression of redox-sensitive caspase activation in human hepatoma cells. Carcinogenesis, 30:1106–1114. 2009.
171.
SongJJ, LeeYJ. Differential role of glutaredoxin and thioredoxin in metabolic oxidative stress-induced activation of apoptosis signal-regulating kinase 1. Biochem J, 373:845–853. 2003.
172.
SongJJ, RheeJG, SuntharalingamM, WalshSA, SpitzDR, LeeYJ. Role of glutaredoxin in metabolic oxidative stress. Glutaredoxin as a sensor of oxidative stress mediated by H2O2. J Biol Chem, 277:46566–46575. 2002.
SparacoM, GaetaLM, TozziG, BertiniE, PastoreA, SimonatiA, SantorelliFM, PiemonteF. Protein glutathionylation in human central nervous system: Potential role in redox regulation of neuronal defense against free radicals. J Neurosci Res, 83:256–263. 2006.
175.
SriramK, O'CallaghanJP. Divergent roles for tumor necrosis factor-alpha in the brain. J Neuroimmune Pharmacol, 2:140–153. 2007.
176.
SteinertJR, ChernovaT, ForsytheID. Nitric oxide signaling in brain function, dysfunction, and dementia. Neuroscientist, 16:435–452. 2010.
177.
SultanaR, PoonHF, CaiJ, PierceWM, MerchantM, KleinJB, MarkesberyWR, ButterfieldDA. Identification of nitrated proteins in Alzheimer's disease brain using a redox proteomics approach. Neurobiol Dis, 22:76–87. 2006.
TaylorER, HurrellF, ShannonRJ, LinTK, HirstJ, MurphyMP. Reversible glutathionylation of complex I increases mitochondrial superoxide formation. J Biol Chem, 278:19603–19610. 2003.
180.
TewKD, TownsendDM. Regulatory functions of glutathione S-transferase P1-1 unrelated to detoxification. Drug Metab Rev, 43:179–193. 2011.
181.
TillementL, LecanuL, PapadopoulosV. Alzheimer's disease: Effects of beta-amyloid on mitochondria. Mitochondrion, 11:13–21. 2011.
182.
TretterL, SiposI, Adam-ViziV. Initiation of neuronal damage by complex I deficiency and oxidative stress in Parkinson's disease. Neurochem Res, 29:569–577. 2004.
183.
vanHJ, WitteME, SchreibeltG, de VriesHE. Radical changes in multiple sclerosis pathogenesis. Biochim Biophys Acta, 1812:141–150. 2011.
184.
VeluCS, NitureSK, DoneanuCE, PattabiramanN, SrivenugopalKS. Human p53 is inhibited by glutathionylation of cysteines present in the proximal DNA-binding domain during oxidative stress. Biochemistry, 46:7765–7780. 2007.
185.
VesceS, JekabsonsMB, Johnson-CadwellLI, NichollsDG. Acute glutathione depletion restricts mitochondrial ATP export in cerebellar granule neurons. J Biol Chem, 280:38720–38728. 2005.
186.
WaakJ, WeberSS, GornerK, SchallC, IchijoH, StehleT, KahlePJ. Oxidizable residues mediating protein stability and cytoprotective interaction of DJ-1 with apoptosis signal-regulating kinase 1. J Biol Chem, 284:14245–14257. 2009.
WangJ, TekleE, OubrahimH, MieyalJJ, StadtmanER, ChockPB. Stable and controllable RNA interference: Investigating the physiological function of glutathionylated actin. Proc Natl Acad Sci USA, 100:5103–5106. 2003.
189.
WangW, OlivaC, LiG, HolmgrenA, LilligCH, KirkKL. Reversible silencing of CFTR chloride channels by glutathionylation. J Gen Physiol, 125:127–141. 2005.
190.
WestMB, HillBG, XuanYT, BhatnagarA. Protein glutathiolation by nitric oxide: An intracellular mechanism regulating redox protein modification. FASEB J, 20:1715–1717. 2006.
XuR, WuC, ZhangX, ZhangQ, YangY, YiJ, YangR, TaoY. Linking hypoxic and oxidative insults to cell death mechanisms in models of ALS. Brain Res, 1372:133–144. 2011.
195.
YangQ, MaoZ. Regulation of MEF2s by chaperone-mediated autophagy. Cell Cycle, 8:1105. 2009.
196.
YangQ, MaoZ. Parkinson disease: A role for autophagy?Neuroscientist, 16:335–341. 2010.
